Neuro-Onc Funding Opportunities June-Dec 2021

October 07, 2021

DeadlineProspectAmount/YearsNotesResearch AreaEligibility
LOI Deadline:
7/31/2021
Last Application Deadline:
10/15/2021
G. Harold & Leila Y. Mathers Charitable Foundation $750,000 /
3 years
Research Grants: Current areas of interest are Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc. Requests for support of clinical trials or drug discovery will not be approved.  This is a DFCI Limited Application. General Grants are made to tax-exempt 501(c)(3) independent and educational institutions. There are no grants awarded to individuals. One application per cycle per investigator. Development offices coordinating applications should submit a limit of 4 applications per cycle per institution/university. 
Application Deadline (Expected):
10/15/2021
American Cancer Society $660,000 /
4 years
The Research Scholar Grant (RSG) supports investigator-initiated projects across the cancer research continuum.

For the RSG award in the Cancer Control and Prevention Research Program with a focus on health equity, the maximum award is for 4 years at up to $165,000 per year (direct costs), plus 20% allowable indirect costs. Additionally, large multilevel studies that address cancer health equity may propose up to a maximum of 5 years and $200,000 per year (direct costs), plus 20% allowable indirect costs. 
General Independent investigators in the first 8 years of an independent research career or faculty appointment are eligible to apply. Eligibility is extended for 10 years for clinician scientists who remain active in clinical care. Applicants typically must be within 14 years of receiving a terminal (doctorate) degree and cannot have more than one R01/R01-like grant (>$100,000/year direct costs for more than 3 years) as principal investigator at the time of application.

 In the Cancer Control and Prevention Research Program, RSG applicants may be at any stage in their career if they focus their project on either: 1) Health Policy/Health Services research or 2) Cancer Health Equity.
LOI Deadline:
8/1/2021
Application Deadline
10/15/21
American Cancer Society $400,000 /
5 years
Clinical Research Professor Award: The American Cancer Society offers a limited number of grants to investigators who have had the rank of full professor for 15 years or less and made seminal contributions in the area of cancer control that have changed the direction of clinical, psychosocial, behavioral, health policy, or epidemiologic cancer research.

It is expected that these investigators will continue to provide leadership in their research area. Up to 2 awards are made annually for a 5-year term that can be renewed once. The award of up to $80,000 per year (direct costs only) may be used for salary or research project support.

Interested individuals should submit their curriculum vitae with a complete bibliography and a letter of intent that briefly describes their seminal contributions to research. 
General ELIGIBILITY: Investigators who have been a full professor for 15 years or less and made seminal contributions that have changed the direction of clinical psychosocial behavioral health policy or epidemiologic can. Priority focus on research addressing cancer health equity and health disparities.

Applicants must:
1. Have a clinical doctoral degree (e.g., MD, DO, DDS, DNP, DSW, PharmD, PsyD, DVM etc.)
with an active license to provide clinical care. Applicants may also hold dual degrees such
as MD/PhD, RD/PhD, DVM/PhD, etc.
2. Be within the first six years of an initial full-time faculty position.
3. Provide justification to support the need for mentoring. Faculty with independent research
programs and/or independent extramural research funding (an NIH R01 or equivalent) may
not apply.
4. At the time of application, have no more than three years of mentored post-doctoral
research training or experience. Applicants who have completed institutional career
development awards (e.g., NIH K12) are eligible, but recipients of individual career
development awards, such as an NIH K07, K08, or K23 grant, are not. 
Full Application Due: 8/1/2021 American Society of Gene & Cell Therapy $100,000 / 1 year ASGCT will award a $100,000 Career Development Award in each of the following six broad topics (six total grants):

Viral Vector Development
Gene Targeting and Gene Correction
Oligonucleotide Therapeutics
Synthetic/Molecular Conjugates and Physical Methods for Delivery of Gene Therapeutics
Cell Therapies
Immunological Aspects of Gene Therapy and Vaccines*
Gene/Cell Therapy Any ASGCT member type who is in good standing, and persons who have a membership application pending may apply

U.S. citizenship is not required but both the applicant and mentor must be located in the United States during the duration of the research. Any visa and/or citizenship restrictions applicable to receiving the award are the responsibility of the applicant
2021 Deadline: TBD

Last Known Deadline:
8/3/2020
Arnold & Mabel Beckman Foundation $600,000 / 4 years  The Beckman Young Investigator (BYI) Program provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences, particularly to foster the invention of methods, instruments and materials that will open up new avenues of research in science. General Prior Grant Cycle Eligibility (Will be updated when new RFP is released)

Early Tenure-Track
The BYI program is open to those within the first three years of a tenure-track position, or an equivalent independent research appointment, at a United States academic or non-profit institution that conducts research in chemical and life sciences.

Tenure-Track dates for the 2021 program must start after 8/6/2017 AND before 8/6/2020.

US Citizenship
Candidates must be citizens or permanent residents of the United States at the time of application. Persons who have applied for permanent residency but have not received their government documentation by the time of application are not eligible. Applicants with conditional residency who have received Form I-797 are eligible to apply.

External Funding
Applicants can have no more than $225,000 in direct, annualized external funding grants during any BYI Program Year (Aug-July) at time of application. Start-up funds, department-wide instrumentation grants, and "Transition" grants (such as NIH K99/R00) are not counted toward this total.
2021 Deadline TBD

Last LOI Deadline:
12/7/2020
Last Application Deadline;
4/26/2021
McKnight Endowment Fund For Neuroscience $200,000 /
2 years
Technological Innovations in Neuroscience Awards support scientists who work on novel and creative approaches to understanding brain function.
The program seeks to advance and enlarge the range of technologies available to the neurosciences. It does not support research based primarily on existing techniques.

The Endowment Fund is especially interested in how technology may be used or adapted to monitor, manipulate, analyze, or model brain function at any level, from the molecular to the entire organism. Technology may take any form, from biochemical tools to instruments to software and mathematical approaches. Because the program seeks to advance and enlarge the range of technologies available to the neurosciences, research based primarily on existing techniques will not be considered.

A goal of the Technological Innovations awards is to foster collaboration between the neurosciences and other disciplines; therefore, collaborative and cross-disciplinary applications are explicitly invited.
Neuroscience/Technology Prior Grant Cycle Eligibility (Will be updated when new RFP is released)

A candidate for a McKnight Technological Innovation in Neuroscience Award must work as an independent investigator at a not-for-profit research institution in the United States, and must hold a faculty position at the rank of Assistant Professor or higher. Those holding other titles such as Research Professor, Adjunct Professor, Professor Research Track, Visiting Professor or Instructor are not eligible. If the host institution does not use professorial titles, a letter from a senior institutional official (e.g. Dean or Director of Research) must confirm that the applicant has his/her own dedicated institutional resources, laboratory space, and/or facilities.

A candidate may not hold another award from the McKnight Endowment Fund for Neuroscience that would overlap in time with the Technological Innovation in Neuroscience Awards award.
2021 Deadline TBD
Last Application Deadline:
11/1/2020
Cancer Research Institute $200,000 /
2 years
The Cancer Research Institute Clinic and Laboratory Integration Program (CLIP) supports pre-clinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. CLIP grants are awarded to qualified scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies.  Immunotherapy Prior Grant Cycle Eligibility (Will be updated when new RFP is released)

CLIP Grants provide funding for qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support pre-clinical and translational research, which will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.

Candidates for a CLIP Grant must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the Letter of Intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad. Please note that CLIP Grants do not support research at for-profit institutions.
2021 Deadline: TBD
Last Application LOI Deadline:
11/13/2020
Last Full Application Deadline:
3/12/2021
Doris Duke Charitable Foundation $495,000 /
3 years
Physician scientists pursuing research careers face challenges that are particular to their dual roles as researchers and health care providers. The purpose of the Doris Duke Clinical Scientist Development Award (CSDA) is to provide support to physician scientists at the Instructor or Assistant Professor rank to: 1) conduct an outstanding clinical research project with high significance to improve human health, 2) enable research time protection to ease the tension between research and clinical responsibilities, and 3) facilitate development of strong mentorship relations in a supportive institutional environment. Ultimately, the CSDA program aims to enable physician scientists’ achievement of independent and successful research careers. General Cancer Research  Prior Grant Cycle Eligibility (Will be updated when new RFP is released)

• Have a valid, active US medical license at the time of application, but do not have to be US citizens.
• Work at a US academic institution that grants doctoral degrees and is able to receive an award as an organization with 501(c)(3) Internal Revenue Service status. Please see the information on page 4 and consult with your institutional grants office.
• Be junior, full-time faculty who have completely finished all training (residency and fellowship, or post-doctoral research if applicable). Adjunct, affiliated, temporary, part-time or acting faculty positions are not eligible for this competition. Applicants that become Associate Professor on or before the award start date of July 1, 2021, will not be eligible for the award.
• Have been appointed to their first post-training, full-time Instructor or Assistant Professor faculty position between December 1, 2016, and December 1, 2019
• Not have served as the principal investigator of an extramural single or multi-principal investigator, multi-year (term >12 months) research grant, cooperative agreement, or contract with annual direct funding in the amount of $225,000 or higher with a start date prior to and inclusive of July 1, 2021.
• Not have applied for a single or multiple-principal investigator NIH R01 research grant or equivalent as principal investigator that has a start date prior to and inclusive of July 1, 2021.
• Be guaranteed a minimum overall research time protection of 75% of full-time professional effort by the institution where the applicant has an appointment, in the event an award is made.
2021 Deadline TBD

Last LOI Deadline:
12/15/2020
Last Application Deadline:
2/28/2021
G. Harold & Leila Y. Mathers Charitable Foundation $750,000 /
3 years
Research Grants: Current areas of interest are Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc. Requests for support of clinical trials or drug discovery will not be approved. General Prior Grant Cycle Eligibility (Will be updated when new RFP is released)

Grants are made to tax-exempt 501(c)(3) independent and educational institutions. There are no grants awarded to individuals. One application per cycle per investigator. Development offices coordinating applications should submit a limit of 4 applications per cycle per institution/university.
2021 Deadline TBD

Last Application Deadline:
12/18/2020
American Association for Cancer Research $225,000 /
3 years
The AACR-Bristol Myers Squibb Midcareer Female Investigator Grant represents a joint effort to encourage and support mid-career female physician-scientists and researchers to conduct immuno-oncology research and to foster their career advancement toward becoming a senior investigator. Research projects may be translational and/or clinical in nature with a focus on immuno-oncology.

The grant provides $225,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators, postdoctoral or clinical research fellows, graduate students, and/or research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses (indirect costs are not permitted).
Immuno-Oncology
Prior Grant Cycle Eligibility (Will be updated when new RFP is released)

Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. Applicants must also have received their first NIH R01 (or equivalent) award within the past 10 years (i.e., grant cannot have been awarded before July 1, 2011).

At the start of the grant term on July 1, 2021, applicants must hold an appointment at the rank of associate professor and work at an academic, medical, or research institution anywhere in the world.

Individuals who are considered "early-stage investigators" (e.g., instructor, assistant professor, research assistant professor, or equivalent) are not eligible to apply. Qualified early-stage investigators are invited to apply for an AACR Career Development Award.

Investigators may submit only one application for the AACR-Bristol Myers Squibb Midcareer Female Investigator Grant but may concurrently apply for other AACR grants. However, applicants are expected to accept the first grant they are awarded. Individuals may accept and hold only one AACR grant at a time. Any individual who currently holds an active AACR grant may not apply. Past AACR grantees may apply if they have complied with all progress and financial report requirements.
RFP Released Nov 2021

LOI Deadline:
December 2021
Application Deadline:
March 2022
American Brain Tumor Association $50,000 /
1 year
Discovery Grants are one-year, $50,000 grants for high-risk/high-impact projects deemed to have the potential to change current diagnostic or treatment paradigms for adult and pediatric brain tumor care.  Brain Tumor Prior Grant Cycle Eligibility (Will be updated when new RFP is released)

Applicants do not have to be U.S. citizens or residents and can be conducting research at a non-profit, non-governmental research institution anywhere in the world.

Applicants do not need to be in a faculty position at the time of application; however, applicants who do not have a full-time faculty position must include a signed offer letter with their Full Application, which includes a start date no later than the start of the grant term. Applicants cannot have held a full-time faculty appointment for more than ten years at the start of the grant term. The Letter of Support (LOS) from the Institution should confirm the position held by the Applicant.

Researchers who hold a doctoral degree, hold a position that is equivalent to a faculty position such as the head of a laboratory or group, and have not been the head of the laboratory for more than ten years at the start of the grant term, are eligible to apply for Discovery Grants, provided that they and their institution meet all the other eligibility criteria. The Letter of Support from the institution (department head) should confirm that the position held is equivalent to a faculty position.